Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03476226 · ClinicalTrials.gov registry record · NA
Cognitive Dysfunction and Breast Cancer Coping Strategies Impact on QOL
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT03476226 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 49 participants.
The verdict
NCT03476226, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether patients experience a better quality of life when they have received education about coping strategies for cognitive dysfunction.
Interventions
- OTHER Cognitive Dysfunction Coping Strategy Teaching Sheet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-11-18 |
| Est. Completion | 2019-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03476226
The ClinicalTrials.gov registry entry for NCT03476226 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Dysfunction Coping Strategy Teaching Sheet is the first listed.
NCT03476226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03476226 about?
NCT03476226 is a clinical study titled "Cognitive Dysfunction and Breast Cancer Coping Strategies Impact on QOL". The purpose of this study is to determine whether patients experience a better quality of life when they have received education about coping strategies for cognitive dysfunction.
What is the current status of trial NCT03476226?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2017-11-18. Estimated completion is 2019-09-01.
What interventions are being tested in trial NCT03476226?
The interventions under investigation include: Cognitive Dysfunction Coping Strategy Teaching Sheet (OTHER).
Who is sponsoring clinical trial NCT03476226?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.